- Home
- AUPH vs BST Comparison
AUPH vs BST Comparison
Compare AUPH & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | BST |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AUPH | BST |
|---|---|---|
| Price | $17.72 | $48.90 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 126.2K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | N/A |
| Revenue Next Year | $15.74 | N/A |
| P/E Ratio | $65.84 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $7.29 | $34.87 |
| 52 Week High | $16.88 | $50.56 |
Technical Indicators
Market Signals| Indicator | AUPH | BST |
|---|---|---|
| Relative Strength Index (RSI) | 71.45 | 61.97 |
| Support Level | $14.60 | $38.90 |
| Resistance Level | N/A | $50.56 |
| Average True Range (ATR) | 0.56 | 1.34 |
| MACD | 0.16 | -0.09 |
| Stochastic Oscillator | 77.97 | 81.56 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objectives are to provide total return and income through long-term capital appreciation.